270 related articles for article (PubMed ID: 34308390)
1. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity.
Sindelar M; Stancliffe E; Schwaiger-Haber M; Anbukumar DS; Adkins-Travis K; Goss CW; O'Halloran JA; Mudd PA; Liu WC; Albrecht RA; García-Sastre A; Shriver LP; Patti GJ
Cell Rep Med; 2021 Aug; 2(8):100369. PubMed ID: 34308390
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity.
Sindelar M; Stancliffe E; Schwaiger-Haber M; Anbukumar DS; Albrecht RA; Liu WC; Travis KA; García-Sastre A; Shriver LP; Patti GJ
medRxiv; 2021 Feb; ():. PubMed ID: 33564793
[TBL] [Abstract][Full Text] [Related]
3. Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.
Ansone L; Briviba M; Silamikelis I; Terentjeva A; Perkons I; Birzniece L; Rovite V; Rozentale B; Viksna L; Kolesova O; Klavins K; Klovins J
Microbiol Spectr; 2021 Dec; 9(3):e0033821. PubMed ID: 34878333
[TBL] [Abstract][Full Text] [Related]
4. Metabolic predictors of COVID-19 mortality and severity: a survival analysis.
Abdallah AM; Doudin A; Sulaiman TO; Jamil O; Arif R; Sada FA; Yassine HM; Elrayess MA; Elzouki AN; Emara MM; Thillaiappan NB; Cyprian FS
Front Immunol; 2024; 15():1353903. PubMed ID: 38799469
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning.
Elgedawy GA; Samir M; Elabd NS; Elsaid HH; Enar M; Salem RH; Montaser BA; AboShabaan HS; Seddik RM; El-Askaeri SM; Omar MM; Helal ML
PLoS One; 2024; 19(5):e0302977. PubMed ID: 38814977
[TBL] [Abstract][Full Text] [Related]
6. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome.
Roberts I; Wright Muelas M; Taylor JM; Davison AS; Xu Y; Grixti JM; Gotts N; Sorokin A; Goodacre R; Kell DB
Metabolomics; 2021 Dec; 18(1):6. PubMed ID: 34928464
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics study of COVID-19 patients in four different clinical stages.
Valdés A; Moreno LO; Rello SR; Orduña A; Bernardo D; Cifuentes A
Sci Rep; 2022 Jan; 12(1):1650. PubMed ID: 35102215
[TBL] [Abstract][Full Text] [Related]
8. Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study.
Byeon SK; Madugundu AK; Garapati K; Ramarajan MG; Saraswat M; Kumar-M P; Hughes T; Shah R; Patnaik MM; Chia N; Ashrafzadeh-Kian S; Yao JD; Pritt BS; Cattaneo R; Salama ME; Zenka RM; Kipp BR; Grebe SKG; Singh RJ; Sadighi Akha AA; Algeciras-Schimnich A; Dasari S; Olson JE; Walsh JR; Venkatakrishnan AJ; Jenkinson G; O'Horo JC; Badley AD; Pandey A
Lancet Digit Health; 2022 Sep; 4(9):e632-e645. PubMed ID: 35835712
[TBL] [Abstract][Full Text] [Related]
9. Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection.
D'Amora P; Silva IDCG; Budib MA; Ayache R; Silva RMS; Silva FC; Appel RM; Júnior SS; Pontes HBD; Alvarenga AC; Arima EC; Martins WG; Silva NLF; Diaz RS; Salzgeber MB; Palma AM; Evans SS; Nagourney RA
PLoS One; 2021; 16(12):e0259909. PubMed ID: 34851990
[TBL] [Abstract][Full Text] [Related]
10. Untargeted detection of the carbonyl metabolome by chemical derivatization and liquid chromatography-tandem mass spectrometry in precursor ion scan mode: Elucidation of COVID-19 severity biomarkers.
Gomez-Gomez A; Rodríguez-Morató J; Haro N; Marín-Corral J; Masclans JR; Pozo OJ
Anal Chim Acta; 2022 Mar; 1196():339405. PubMed ID: 35151400
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients.
Marín-Corral J; Rodríguez-Morató J; Gomez-Gomez A; Pascual-Guardia S; Muñoz-Bermúdez R; Salazar-Degracia A; Pérez-Terán P; Restrepo MI; Khymenets O; Haro N; Masclans JR; Pozo OJ
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946479
[TBL] [Abstract][Full Text] [Related]
12. Biological and Clinical Factors Contributing to the Metabolic Heterogeneity of Hospitalized Patients with and without COVID-19.
D'Alessandro A; Thomas T; Akpan IJ; Reisz JA; Cendali FI; Gamboni F; Nemkov T; Thangaraju K; Katneni U; Tanaka K; Kahn S; Wei AZ; Valk JE; Hudson KE; Roh D; Moriconi C; Zimring JC; Hod EA; Spitalnik SL; Buehler PW; Francis RO
Cells; 2021 Sep; 10(9):. PubMed ID: 34571942
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis.
Albóniga OE; Jiménez D; Sánchez-Conde M; Vizcarra P; Ron R; Herrera S; Martínez-Sanz J; Moreno E; Moreno S; Barbas C; Serrano-Villar S
J Proteome Res; 2022 Mar; 21(3):623-634. PubMed ID: 35133846
[TBL] [Abstract][Full Text] [Related]
14. Comparing plasma and skin imprint metabolic profiles in COVID-19 diagnosis and severity assessment.
Delafiori J; Siciliano RF; de Oliveira AN; Nicolau JC; Sales GM; Dalçóquio TF; Busanello ENB; Eguti A; de Oliveira DN; Bertolin AJ; Dos Santos LA; Salsoso R; Marcondes-Braga FG; Durán N; Júnior MWP; Sabino EC; Reis LO; Fávaro WJ; Catharino RR
J Mol Med (Berl); 2024 Feb; 102(2):183-195. PubMed ID: 38010437
[TBL] [Abstract][Full Text] [Related]
15. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism.
Blasco H; Bessy C; Plantier L; Lefevre A; Piver E; Bernard L; Marlet J; Stefic K; Benz-de Bretagne I; Cannet P; Lumbu H; Morel T; Boulard P; Andres CR; Vourc'h P; Hérault O; Guillon A; Emond P
Sci Rep; 2020 Oct; 10(1):16824. PubMed ID: 33033346
[TBL] [Abstract][Full Text] [Related]
16. Automated machine learning optimizes and accelerates predictive modeling from COVID-19 high throughput datasets.
Papoutsoglou G; Karaglani M; Lagani V; Thomson N; Røe OD; Tsamardinos I; Chatzaki E
Sci Rep; 2021 Jul; 11(1):15107. PubMed ID: 34302024
[TBL] [Abstract][Full Text] [Related]
17. Plasma profiling reveals a blood-based metabolic fingerprint of obstructive sleep apnea.
Pinilla L; Benítez ID; Santamaria-Martos F; Targa A; Moncusí-Moix A; Dalmases M; Mínguez O; Aguilà M; Jové M; Sol J; Pamplona R; Barbé F; Sánchez-de-la-Torre M
Biomed Pharmacother; 2022 Jan; 145():112425. PubMed ID: 34800782
[TBL] [Abstract][Full Text] [Related]
18. Saliva metabolomic profile of COVID-19 patients associates with disease severity.
Saheb Sharif-Askari N; Soares NC; Mohamed HA; Saheb Sharif-Askari F; Alsayed HAH; Al-Hroub H; Salameh L; Osman RS; Mahboub B; Hamid Q; Semreen MH; Halwani R
Metabolomics; 2022 Oct; 18(11):81. PubMed ID: 36271948
[TBL] [Abstract][Full Text] [Related]
19. Determination of prognostic markers for COVID-19 disease severity using routine blood tests and machine learning.
Lima TE; Ferraz MVF; Brito CAA; Ximenes PB; Mariz CA; Braga C; Wallau GL; Viana IFT; Lins RD
An Acad Bras Cienc; 2024; 96(2):e20230894. PubMed ID: 38922277
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
